Fowler, Mary Glenn.Qin, Min.Fiscus, Susan A.Currier, Judith S.Flynn, Patricia M.Chipato, Tsungai.McIntyre, James.Gnanashanmugam, Devasena.Siberry, George K.Coletti, Anne S.Taha, Taha E.Klingman, Karin L.Martinson, Francis E.Owor, Maxensia.Violari, Avy.Moodley, Dhayendre.Theron, Gerhard.Bhosale, Ramesh.Bobat, Raziya Ahmed.Chi, Benjamin H.Strehlau, Renate.Mlay, Pendo.Loftis, Amy J.Browning, Renee.Fenton, Terence.Purdue, Lynette.Basar, Michael.Shapiro, David E.Mofenson, Lynne Meryl.2018-10-112018-10-1120162016Fowler, M.G., Qin, M., Fiscus, S.A., Currier, J.S., Flynn, P.M., Chipato, T., McIntyre, J., Gnanashanmugam, D., Siberry, G.K., Coletti, A.S., Taha, T.E., Klingman, K.L., Martinson, F.E., Owor, M., Violari, A., Moodley, D., Theron, G.B., Bhosale, R., Bobat, R., Chi, B.H., Strehlau, R., Mlay,P., Loftis, A.J., Browning, R., Fenton, T., Purdue, L., Basar, M., Shapiro, D.E. and Mofenson, L.M. 2016. Benefits and risks of antiretroviral therapy for perinatal HIV prevention. New England Journal of Medicine 375(18), 1726-1737.http://hdl.handle.net/10413/15622CAPRISA, 2016.Abstract available in pdf.enAntiretroviral agents--Adverse effects.CD4 lymphocyte count.Drug therapy, Combination.Benefits and risks of antiretroviral therapy for perinatal HIV prevention.Peer reviewed journal article